Media promotion conference on NanoKnife Therapy for cancer was held in the conference room of Guangzhou Fuda Cancer Hospital, October 27, 2015. Chief President Xu Kecheng, the founder of Fuda together with General Manager Liu Jianguo and President Niu Lizhi attended the conference and made special report. Over a dozen of media including China News Service, Nanfang Daily, Yangcheng Evening News, Guangzhou Daily, Information Times, Southern Metropolis Daily, News Express, Guangdong TV and Guangzhou TV attended the conference and make special coverage.
Liu Jianguo, General Manager of Fuda Cancer Hospital is delivering a keynote speech
The media promotion conference started with the keynoted speech--Walk Into Fuda and Learn About FUDA--delivered by Liu Jianguo, General Manager of Guangzhou Fuda Cancer Hospital. He introduced to friends from media the development concept, development history, featured technology and services, medical team & personnel development and scientific research progress of FUDA with a focus on the introduction of FUDA’s cultural construction and charity activities.
Media Friends
Prof. Xu Kecheng, the Chief President of Guangzhou Fuda Cancer Hospital, as well as a cancer survivor, shared his anti-cancer experience with the participants. He emphasized,“ As we are running a cancer hospital, we have been placing patient in the first place, fully committed to scientific innovations with the aim of providing the best medical technologies for our patient. Though death is inevitable, we can prolong patient’s lifespan, improve their quality of life, and render an easier life for them with our featured technology. NanoKnife therapy (IRE) is another fine example of scientific and technological innovation.”
It is reported that the Nanoknife system is a nonthermal and novel minimally-invasive technology for tumor ablation. It is also known as Irreversible Electroporation (IRE). Its rationale goes like as follows: during the procedure, high electric-field and ultrashort pulses are given to destroy lipid bilayer structure of cancer cell membrane and form numerous irreversible nano-sized pores in the cell membrane. Cell membrane permeability will be changed to allow molecules of different sizes free access to cells, which will lead to cell death. As it causes no heat island effect, it inflicts no incomplete treatment or thermal injury. Tumor cells besides blood vessels can also be completely eliminated.IRE is formally approved by China for clinical application in June 2015. Guangzhou Fuda Cancer Hospital became the first in Mainland of China to introduce NanoKnife system. On July 2, the medical team led by Dr. Niu Lizhi performed the first NanoKnife therapy for pancreatic cancer, which has delivered remarkable curative effects. Under the leadership of Niu Lizhi, medical team at FUDA has carried out NanoKnife therapy for over 40 cancer patient, all of which have produced remarkable curative effects.
President Niu is introducing NanoKnife therapy
On the conference, Niu Lizhi pointed out that NanoKnife therapy for cancer falls into the category of minimally invasive treatment and inflicts no injuries to such tissue structures as blood vessels, bile duct and nerves adjacent to tumor. Electrode of 1mm in diameter is inserted into tumor percutaneously and then computer technology calculates and predicts the location and size of electric field. Electrodes releases high electricity and ultrashort pulses to form strong electric field and make numerous irreversible nano-sized pores in the cell membrane, which will lead to cell death. After treatment, human body will activate healing response, absorb apoptotic cell and replace tumor with new cells.
A 61-year-old man from middle east, Prof. Pratibha Rajgopal from India and Ms. Wang, a former hostess of Hubei TV station all suffered from pancreatic cancer and received NanoKnife therapy at FUDA. The procedure went well with short operative time. Patients had good postoperative recovery and achieved remarkable curative effects.
Patient representative is making a speech
At present, NanoKnife therapy has made remarkable achievement in the field of pancreatic cancer treatment. Niu Lizhi said pancreatic cancer is a highly malignant digestive tract tumor with high mortality. The reason behind the high mortality is that 80% pancreatic cancer patients have local progression or metastases upon diagnosis, thus the tumor is unresectable and not responding well to chemotherapy and radiotherapy. As IRE is free from the influence of ambient temperature, it can effectively ablate tissues surrounding great vessels, limit damage to extracellular matrix and protect great vessels and bile duct structure. Therefore, IRE is the best treatment for pancreatic cancer that is adjacent to such lumen as portal vein, deep vein, and common bile duct.
Media friends are making an interview with President Niu Lizhi